Asuragen In-licenses BRAF Mutation from Johns Hopkins

Asuragen will incorporate the mutation into diagnostic test kits and use it in its clinical lab for research and patient testing.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.